BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23445171)

  • 1. Versatile fluorescence resonance energy transfer-based mesoporous silica nanoparticles for real-time monitoring of drug release.
    Lai J; Shah BP; Garfunkel E; Lee KB
    ACS Nano; 2013 Mar; 7(3):2741-50. PubMed ID: 23445171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-marker-mediated "on-demand" drug release and real-time monitoring system based on multifunctional mesoporous silica nanoparticles.
    Li XL; Hao N; Chen HY; Xu JJ
    Anal Chem; 2014 Oct; 86(20):10239-45. PubMed ID: 25264685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
    Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-Time Monitoring of ATP-Responsive Drug Release Using Mesoporous-Silica-Coated Multicolor Upconversion Nanoparticles.
    Lai J; Shah BP; Zhang Y; Yang L; Lee KB
    ACS Nano; 2015 May; 9(5):5234-45. PubMed ID: 25859611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intelligent Janus nanoparticles for intracellular real-time monitoring of dual drug release.
    Cao H; Yang Y; Chen X; Shao Z
    Nanoscale; 2016 Mar; 8(12):6754-60. PubMed ID: 26952741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
    Xie Z; Gong H; Liu M; Zhu H; Sun H
    J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptamer/Graphene Quantum Dots Nanocomposite Capped Fluorescent Mesoporous Silica Nanoparticles for Intracellular Drug Delivery and Real-Time Monitoring of Drug Release.
    Zheng FF; Zhang PH; Xi Y; Chen JJ; Li LL; Zhu JJ
    Anal Chem; 2015 Dec; 87(23):11739-45. PubMed ID: 26524192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-responsive smart cyclodextrin-gated mesoporous silica nanoparticles with ligand-receptor engagement for anti-cancer treatment.
    Wu Y; Xu Z; Sun W; Yang Y; Jin H; Qiu L; Chen J; Chen J
    Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109831. PubMed ID: 31349481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prominent anchoring effect on the kinetic control of drug release from mesoporous silica nanoparticles (MSNs).
    Tran VA; Lee SW
    J Colloid Interface Sci; 2018 Jan; 510():345-356. PubMed ID: 28961433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
    Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
    Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug delivery.
    Zhao Q; Geng H; Wang Y; Gao Y; Huang J; Wang Y; Zhang J; Wang S
    ACS Appl Mater Interfaces; 2014 Nov; 6(22):20290-9. PubMed ID: 25311422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
    Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
    Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox-responsive nanocarriers for drug and gene co-delivery based on chitosan derivatives modified mesoporous silica nanoparticles.
    Lin JT; Liu ZK; Zhu QL; Rong XH; Liang CL; Wang J; Ma D; Sun J; Wang GH
    Colloids Surf B Biointerfaces; 2017 Jul; 155():41-50. PubMed ID: 28407530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIE/FRET-based versatile PEG-Pep-TPE/DOX nanoparticles for cancer therapy and real-time drug release monitoring.
    Wang TT; Wei QC; Zhang ZT; Lin MT; Chen JJ; Zhou Y; Guo NN; Zhong XC; Xu WH; Liu ZX; Han M; Gao JQ
    Biomater Sci; 2020 Jan; 8(1):118-124. PubMed ID: 31777865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox-responsive nanocarrier based on heparin end-capped mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo.
    Dai L; Li J; Zhang B; Liu J; Luo Z; Cai K
    Langmuir; 2014 Jul; 30(26):7867-77. PubMed ID: 24933090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesoporous silica nanoparticles capped with disulfide-linked PEG gatekeepers for glutathione-mediated controlled release.
    Cui Y; Dong H; Cai X; Wang D; Li Y
    ACS Appl Mater Interfaces; 2012 Jun; 4(6):3177-83. PubMed ID: 22646097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A graphene quantum dot-based FRET system for nuclear-targeted and real-time monitoring of drug delivery.
    Chen H; Wang Z; Zong S; Chen P; Zhu D; Wu L; Cui Y
    Nanoscale; 2015 Oct; 7(37):15477-86. PubMed ID: 26346491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescent carbon dot modified mesoporous silica nanocarriers for redox-responsive controlled drug delivery and bioimaging.
    Jiao J; Liu C; Li X; Liu J; Di D; Zhang Y; Zhao Q; Wang S
    J Colloid Interface Sci; 2016 Dec; 483():343-352. PubMed ID: 27569517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan-Gated Fluorescent Mesoporous Silica Nanocarriers for the Real-Time Monitoring of Drug Release.
    Chen Y; Lu W; Guo Y; Zhu Y; Song Y
    Langmuir; 2020 Jun; 36(24):6749-6756. PubMed ID: 32419468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabrication of autofluorescent porous silica nanoparticles for redox-responsive drug release.
    Cao N; Zhao Y; Sang B; Wang Z; Cao L; Sun L; Zou X
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():330-6. PubMed ID: 27612720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.